Holen Sie sich die Stockscreener-App
208.84
2.86%
-6.14
Handel nachbörslich:
208.27
-0.57
-0.27%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ABBV?
Forum
Prognose
Dividendenhistorie
Abbvie Inc Aktie (ABBV) Neueste Nachrichten
AbbVie Updates 2026 Adjusted EPS Guidance to $13.96–$14.16 Including Q1 Acquired IPR&D and Milestones Expense 1 - Minichart
AbbVie Inc. $ABBV Shares Bought by SteelPeak Wealth LLC - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Acquires 6,946 Shares of AbbVie Inc. $ABBV - MarketBeat
C2P Capital Advisory Group Trims AbbVie Stake - National Today
C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Sells 8,610 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie reports $744 million IPR&D expense for Q1, updates 2026 earnings guidance - Investing.com
AbbVie & Amgen: Safe Dividend Stocks for Recession Fears | 2026News and Statistics - IndexBox
Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034 – DelveInsight | Visiox Pharma, TearClear, VivaVision Biotech, Abbvie, Ocuphire Pharma, Qlaris Bio, Nicox Ophthalmics, Sun Pharma - barchart.com
AbbVie Posts Record $61B Revenue as Skyrizi and Rinvoq Surge Past Peak Humira Sales - TIKR.com
Potential US Drug Tariffs Test AbbVie Margins And Growth Narrative - Yahoo Finance
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know - Yahoo Finance
Global pharma companies that have publicly announced Trump drug pricing agreements - Reuters
2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory - The Motley Fool
AbbVie Inc Stock (ABBV) Moved Down by 3.20% on Apr 2: A Full Analysis - tradingkey.com
AbbVie stock price forecast: Downside risk builds as ABBV drops 3.07% to $208 - Traders Union
AbbVie Inc. $ABBV Shares Sold by Trust Co. of Vermont - MarketBeat
Assessing AbbVie (ABBV) Valuation After New Dermatology Data And FDA Label Update - Yahoo Finance
Compagnie Lombard Odier SCmA Raises Holdings in AbbVie Inc. $ABBV - MarketBeat
Banque Pictet & Cie SA Has $88.87 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
What You Need to Know Ahead of AbbVie’s Earnings Release - Barchart
AbbVie Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Thrivent Moderate Allocation Fund's AbbVie Inc(ABBV) Holding History - gurufocus.com
AbbVie Inc. $ABBV Stock Holdings Trimmed by Vaughan Nelson Investment Management L.P. - MarketBeat
Nisa Investment Advisors LLC Has $156 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Moody Lynn & Lieberson LLC Has $43.98 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Meyer Handelman Co. Boosts Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Sarcopenia Treatments Market Is Going to Boom | AbbVie • Amgen • Pfizer • Novartis - openPR.com
AbbVie Inc. $ABBV Shares Bought by Capital Advisors Inc. OK - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
AbbVie (NYSE:ABBV) Shares Up 2%Time to Buy? - MarketBeat
AbbVie Inc. stock rises Tuesday, still underperforms market - MarketWatch
Pfizer, Bain Must Litigate Cerevel Investors’ AbbVie Deal Suit - Bloomberg Law News
ABBV Stock Quote Price and Forecast - CNN
Bernstein Maintains AbbVie(ABBV.US) With Hold Rating, Maintains Target Price $225 - 富途牛牛
AbbVie Inc Stock (ABBV) Moved Up by 3.26% on Mar 31: Drivers Behind the Movement - TradingKey
/C O R R E C T I O N -- AbbVie/ - Investing News Network
Will AbbVie's Oncology Drugs Aid Top Line in 2026? - The Globe and Mail
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting - Investing News Network
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting® - AbbVie News Center
AbbVie to Host First-Quarter 2026 Earnings Call - National Today
AbbVie to Host First-Quarter 2026 Earnings Conference Call - Moomoo
Range Financial Group LLC Has $1.08 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
J. Safra Sarasin Holding AG Reduces AbbVie Stake - National Today
J. Safra Sarasin Holding AG Sells 36,172 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Holdings Lifted by Mn Services Vermogensbeheer B.V. - MarketBeat
Brookstone Capital Management Sells 6,299 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Stock Price Rises 1.8%, Analysts Weigh In - National Today
AbbVie (NYSE:ABBV) Stock Price Up 1.8%Should You Buy? - MarketBeat
AbbVie (ABBV) Gains As Market Dips: What You Should Know - Yahoo Finance
AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch
U.S. Naproxen Market Set for Dynamic Boom as Key Players AbbVie • Bayer • Amgen • Teva Pharmaceuticals - openPR.com
Gross profit of AbbVie, Inc. – BSESOF:4AB - TradingView
-0.83% for AbbVie stock as shares remain under key resistance levels - Traders Union
-0.83% for AbbVie stock as price remains below key moving averages - Traders Union
AbbVie Inc. $ABBV Stock Position Raised by TrueMark Investments LLC - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Stegent Equity Advisors Inc. - MarketBeat
AbbVie, Inc. Trade Ideas — BSESOF:4AB - TradingView
Taxes of AbbVie, Inc. – BSESOF:4AB - TradingView
Waycross Partners Increases AbbVie Stock Holdings - National Today
Wedge Capital Management L L P NC Sells 6,019 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Stock Holdings Lifted by Waycross Partners LLC - MarketBeat
Bell Bank Reduces Stake in AbbVie by 12.2% - National Today
Is AbbVie Inc. (ABBV) one of the debt free halal stocks to buy? - MSN
Bell Bank Has $12.09 Million Stake in AbbVie Inc. $ABBV - MarketBeat
1.37%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):